speb/financial-data huggingface dataset:
ALKYLAMINE.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
ALKYLAMINE.NS balance_sheet (annual, 2023-03-31) — Payables: 2554329000.00
ALKYLAMINE.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 42605000.00
ALKYLAMINE.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 42800000.00
ALKYLAMINE.NS income_statement (annual, 2023-03-31) — Pretax Income: 3085587000.00
ALKYLAMINE.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
ALKYLAMINE.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 0.00
ALKYLAMINE.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: 0.00
ALKYLAMINE.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -3034252000.00
ALKYLAMINE.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 896381000.00
ALKYLAMINE.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 8808593000.00
ALKYLAMINE.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 451732000.00
ALKYLAMINE.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 1103000.00
ALKYLAMINE.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 1103000.00
ALKYLAMINE.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -736223000.00
ALKYLAMINE.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 10463000.00
ALKYLAMINE.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 10993320000.00
ALKYLAMINE.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 0.00
ALKYLAMINE.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 4430000.00
ALKYLAMINE.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 737616000.00
ALKYLAMINE.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 819031000.00
ALKYLAMINE.NS balance_sheet (annual, 2023-03-31) — Share Issued: 51100628.00
ALKYLAMINE.NS income_statement (annual, 2023-03-31) — Special Income Charges: -39317000.00
ALKYLAMINE.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 13231000.00
ALKYLAMINE.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 11689264000.00
ALKYLAMINE.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 11653336000.00
ALKYLAMINE.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -10181407.87
ALKYLAMINE.NS income_statement (annual, 2023-03-31) — Tax Provision: 799034000.00
ALKYLAMINE.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.26
ALKYLAMINE.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 299760000.00
ALKYLAMINE.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -713952000.00
ALKYLAMINE.NS balance_sheet (annual, 2023-03-31) — Total Assets: 15919130000.00
ALKYLAMINE.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 11689264000.00
ALKYLAMINE.NS balance_sheet (annual, 2023-03-31) — Total Debt: 877452000.00
ALKYLAMINE.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 11689264000.00
ALKYLAMINE.NS income_statement (annual, 2023-03-31) — Total Expenses: 13533035000.00
ALKYLAMINE.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 4229866000.00
ALKYLAMINE.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 10912713000.00
ALKYLAMINE.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 688126000.00
ALKYLAMINE.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 5913000.00
ALKYLAMINE.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -39317000.00
ALKYLAMINE.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -39317000.00
ALKYLAMINE.NS balance_sheet (annual, 2023-03-31) — Tradeand Other Payables Non Current: 8117000.00
ALKYLAMINE.NS balance_sheet (annual, 2023-03-31) — Work In Process: 81720000.00
ALKYLAMINE.NS balance_sheet (annual, 2023-03-31) — Working Capital: 1464677000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — +Operating Expense: 4342652000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — +Total Revenue: 14189986000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 1719000000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 2213414000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -2271054000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 205394000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Amortization: 5462000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 5462000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 42900000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 51114726.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Basic EPS: 29.13
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 171837000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 1202751000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -1223188000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 25306000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 102321000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 303707000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 303858000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -511139000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 212000000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 91707000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 116975000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 220263000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -117592000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Change In Payable: -178162000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Change In Receivables: 365291000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 402935000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 131870000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Common Stock: 102321000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 12671444000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 8221000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 355733000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 7882565000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Current Assets: 4433555000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 6087000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Current Debt: 6372000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 12459000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 2274301000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 36700000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Depreciation: 583763000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 589225000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 589225000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 583763000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 51180494.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Diluted EPS: 29.09
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 1488731000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 9893000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — EBIT: 2062601000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — EBITDA: 2651826000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — End Cash Position: 303707000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -1401370000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 836857000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 1524703000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -291000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 79366000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 37370000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 2213414000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 13481665000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Gross Profit: 6307421000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Hedging Assets Current: 0.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Impairment Of Capital Assets: 26031000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Interest Expense: 37921000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 37921000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Interest Income: 9038000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 9038000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -42462000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 8775000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Inventories Adjustments Allowances: -4165000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Inventory: 1719655000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 12677816000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -1214651000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 0.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 8221000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 2572755000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 312190000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 19219000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 19219000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 2572755000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -3421237000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 106900000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 11063205000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 8221000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 1437000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Net Income: 1488731000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 1488731000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 1488731000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 1488731000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 1488731000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 2024680000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 1488731000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Net Interest Income: -33104000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -848482000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -848482000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -33104000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: 8100000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -2948000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Net PPE: 11210611000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -1220478000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 12634074000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 6943000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 757468000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 106866000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 60439000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 2679400000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Normalized Income: 1509005941.52
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 2747891000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Operating Income: 1964769000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Operating Revenue: 14189986000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 51121395.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 76653000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 2270000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 37310000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 37370000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 76665000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 31019000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 27107000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 722000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 2324234000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Other Payable: 417671000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Other Properties: 547786000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 20233000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 151000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Other Special Charges: 1543000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Payables: 2146564000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 45268000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 15587000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Pretax Income: 2024680000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -1223188000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 704919000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 7882565000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 589225000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 2748000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 2748000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -3421237000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 9893000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 11956146000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 2710000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 472731000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 552097000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Share Issued: 51121395.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Special Income Charges: -27574000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 11026000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 12671444000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 12634074000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -7299058.48
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Tax Provision: 535949000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.26
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 74262000.00
ALKYLAMINE.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -345672000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Total Assets: 15836241000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 12671444000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Total Debt: 31678000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 12671444000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Total Expenses: 12225217000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 3164797000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 11402686000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 890496000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 4221000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -27574000.00
ALKYLAMINE.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -27574000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Tradeand Other Payables Non Current: 20504000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 0.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Work In Process: 105379000.00
ALKYLAMINE.NS balance_sheet (annual, 2024-03-31) — Working Capital: 2159254000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 2044100000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 2345200000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 42200000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 22300000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 102400000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 1038400000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 1359000000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 102400000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 13119600000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 329400000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 5486800000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 4900000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 0.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 4900000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 2576600000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 32000000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 32500000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 10941800000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 1620900000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 13119600000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 42200000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 17400000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 17400000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 115200000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 10941800000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 13087100000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Revenue: 397600000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 809700000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 51136038.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 160700000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 121800000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 13017200000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 484700000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 10612400000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 1000000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 320600000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Payables: 2044100000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 51136038.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 13119600000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 13087100000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 17050100000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 13119600000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 22300000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 13119600000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 3930500000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 11563300000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 1353900000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Tradeand Other Payables Non Current: 14000000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 2910200000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 1268300000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 3712000000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 51121495.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 8.56
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 1916300000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 179300000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 179300000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 51181287.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 8.55
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 437600000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — EBIT: 593400000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — EBITDA: 772700000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 1795700000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 2900000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 2900000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Net Income: 437600000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 437600000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 437600000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 437600000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 437600000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 437600000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -2900000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -2900000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 772700000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 437600000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Operating Income: 527400000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 3712000000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 66000000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 828100000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 590500000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 1916300000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 179300000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 152900000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.26
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 3184600000.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
ALKYLAMINE.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — +Operating Expense: 4593903000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 1269200000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — +Total Revenue: 15481961000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 3860500000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 1772336000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1772336000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 2301514000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 2301514000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -2951649000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -2951649000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 215961000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 215961000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Amortization: 5318000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 5318000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 39800000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 39800000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 51131827.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 51133333.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Basic EPS: 36.40
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 9.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 303707000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 1216810000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 1216810000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -476879000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 19219000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 19219000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 102351000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 102351000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 487787000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 487787000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 2028328000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 2028328000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -511310000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 336000000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 336000000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 151787000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 151787000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Change In Inventory: 71847000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -36400000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 70300000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Change In Payable: 49640000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -94396000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 55617000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 184079000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Common Stock: 102351000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 102351000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 14024844000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 14024844000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 6204000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 519134000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 519134000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 8623550000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2089300000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Current Assets: 6301163000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 6301163000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 7334000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 7334000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Current Debt: 36045000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 36045000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 43379000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 43379000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 2451566000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 2451566000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 36200000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 36200000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Depreciation: 707036000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 712354000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 712354000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 176100000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 707036000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 176100000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 51193933.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 51190211.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Diluted EPS: 36.35
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 8.99
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 1861144000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 460200000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 12230000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 12230000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — EBIT: 2492140000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — EBIT: 595200000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — EBITDA: 3204494000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — EBITDA: 771300000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — End Cash Position: 487787000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -491608000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 811571000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 811571000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 2154180000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -3475000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 93445000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 31249000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 31249000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 2301514000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 2301514000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 13884564000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 13884564000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Gross Profit: 6858411000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 1771200000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Impairment Of Capital Assets: 0.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Interest Expense: 5722000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 1700000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 5722000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 1700000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Interest Income: 82189000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 82189000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -8227000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 50453000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Inventories Adjustments Allowances: -5775000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Inventories Adjustments Allowances: -5775000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Inventory: 1647808000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 1647808000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 14060889000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 14060889000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -1955372000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 0.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 0.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 6204000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 29673000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 312190000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 312190000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 11885000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 11885000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 11885000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 11885000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 29673000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: 0.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 116600000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 116600000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 11282714000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 11282714000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 6204000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 5489000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Net Income: 1861144000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Net Income: 460200000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 1861144000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 460200000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 1861144000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 460200000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1861144000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 460200000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1861144000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 460200000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 2486418000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 1861144000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 460200000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Net Interest Income: 72101000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -1700000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 0.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 29673000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 29673000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: 72101000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -1700000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: 6100000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -1537063000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Net PPE: 10932915000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 10932915000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -468762000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 13993595000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 13993595000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 395494000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 395494000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 888169000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 888169000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 116620000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 116620000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 75568000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 75568000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 3199328000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 771300000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Normalized Income: 1857277124.07
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 460200000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 2631059000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Operating Income: 2264508000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Operating Income: 502000000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Operating Revenue: 15481961000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 3860500000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 51136418.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 51136418.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 82832000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 82832000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 280000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 280000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 39432000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 39432000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 31249000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 31249000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 66670000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 66670000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -129731000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 27107000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 27107000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 20501000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 93200000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 2245375000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 844900000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Other Payable: 448448000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 448448000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Other Properties: 553716000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 553716000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 105163000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 105163000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 1540541000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 1540541000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Other Special Charges: -5166000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Payables: 2233014000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Payables: 2233014000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 46039000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 46039000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 10856000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 10856000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Pretax Income: 2486418000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 593500000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: 0.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -476879000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 688632000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 688632000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 8623550000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2089300000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 712354000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 176100000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 3480000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 3480000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: 0.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 12230000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 12230000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 13299591000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 13299591000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 8117000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 646986000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 740431000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Share Issued: 51136418.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 51136418.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Special Income Charges: 5166000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 6515000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 14024844000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 14024844000.00